Atypical nonketotic hyperglycinemia with normal cerebrospinal fluid to plasma glycine ratio

Journal of Child Neurology

Volumn 14, Issue 7, 1999, Pages 464-467

  Applegarth, Derek A ^a   Toone, Jennifer R ^b   Kure, Shigeo ^b   Levy, Harvey L ^c   Jackson, Anthony H ^d  

^a BC CHILDREN S HOSPITAL   (Canada)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c HARVARD MEDICAL SCHOOL   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BENZOIC ACID; CARBAMAZEPINE; GLYCINE; HIPPURIC ACID; PHENYTOIN; PRIMIDONE; VALPROIC ACID;

ADOLESCENT; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID; CHILD; COMPUTER ASSISTED TOMOGRAPHY; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; HYPERGLYCINEMIA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA; PRIORITY JOURNAL; RASH; SEIZURE;

EID: 0032775086     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389901400710     Document Type: Article

References (31)

1. Hamosh A, Johnston MV, Valle D: Nonketotic hyperglycinemia, in Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The Metabolic and Molecular Bases of Inherited Disease, 7th ed. New York, McGraw-Hill, 1995, pp 1337-1348.
2. Tada K: Nonketotic hyperglycinemia: Clinical and metabolic aspects. Enzyme 1987;38:27-35.
3. Steiner RD, Sweetser DA, Rohrbaugh JR, et al: Nonketotic hyperglycinemia: Atypical clinical and biochemical manifestations. J Pediatr 1996;128:243-246.
4. Wraith JE: Nonketotic hyperglycinaemia: Prolonged survival in a patient with a mild variant. J Inherit Metab Dis 1996;19:695-696.
5. Haan EA, Kirby DM, Tada K, et al: Difficulties in assessing the effect of strychnine on the outcome of nonketotic hyperglcycinaemia. Observations on sisters with a mild T-protein defect. Eur J Pediatr 1986; 145:267-270.
6. Borrone C, Bachmann C, DiRocco M, et al: Atypical nonketotic hyperglycinaemia. J Inherit Metab Dis 1986;9:402-403.
7. Trauner DA, Page T, Greco C, et al: Progressive neurodegenerative disorder in a patient with nonketotic hyperglycinemia. J Pediatr 1981;98: 272-275.
8. Bank WJ, Morrow G: A familial spinal cord disorder with hyperglycinemia. Arch Neurol 1972;27:136-144.
9. Steiman GS, Yudkoff M, Berman PH, et al: Late-onset nonketotic hyperglycinemia and spinocerebellar degeneration. J Pediatr 1979;94: 907-911.
10. Kikuchi G: The glycine cleavage system: Composition, reaction mechanism, and physiological significance. Mol Cell Biochem 1973;1:169-187.
11. Hayasaka K, Tada K, Fueki N, et al: Nonketotic hyperglycinemia: Analyses of glycine cleavage system in typical and atypical cases. J Pediatr 1987;110:873-877.
12. Kure S, Narisawa K, Tada K: Enzymatic diagnosis of nonketotic hyperglycinemia with lymphoblasts. J Pediatr 1992;120:95-98.
13. Christodoulou J, Kure S, Hayasaka K, Clarke JTR: Atypical nonketotic hyperglcyinemia confirmed by assay of the glycine cleavage system in lymphoblasts. J Pediatr 1993;123:100-102.
14. Levy HL, Nishimura RN, Erickson AM, Janowska SE: Hyperglycinemia: In vivo comparison of nonketotic and ketotic (propionic acidemia) forms. I. CSF glycine concentrations and blood/CSF glycine. Pediatr Res 1972;6:400.
15. Perry TL, Urquhart N, McLean J, et al: Nonketotic hyperglycinemia. N Engl J Med 1975;292:1269-1273.
16. Hayasaka K, Narisawa K, Satoh T, et al: Glycine cleavage system in ketotic hyperglycinemia. Pediatr Res 1982;16:5-7.
17. Chace DH, Hillman SL, Van Hove JLK, Naylor EW: Rapid diagnosis of MCAD. Quantitative analysis of octanoylcarnitine and other acylcarnitines by MS/MS. Clin Chem 1997;43:2106-2113.
18. Hayasaka K, Tada K, Fueki N, Aikawa J: Prenatal diagnosis of nonketotic hyperglycinemia: Enzymatic analysis of the glycine cleavage in chorionic villi. J Pediatr 1990;116:444-445.
19. Jaeken J, Corbeel L, Casaer P, et al: Dipropylacetate (valproate) and glycine metabolism. Lancet 1977;2:617.
20. Applegarth DA, Poon S: Interpretation of elevated blood glycine levels in children. Clin Chim Acta 1975;63:49-54.
21. Singer HS, Valle D, Hayasaka K, Tada K: Nonketotic hyperglycinemia: Studies in an atypical variant. Neurology 1989;39:286-288.
22. Ando T, Nyhan WL, Bicknell J, et al: Nonketotic hyperglycinaemia in a family with an unusual phenotype. J Inherit Metab Dis 1978;1:79-83.
23. Coulter DL, Allen RJ: Hyperammonemia with valproic acid therapy. J Pediatr 1981;99:317-319.
24. Kure S, Narisawa K, Tada K: Structural and expression analyses of normal and mutant mRNA encoding glycine decarboxylase: Three-base deletion in mRNA causes nonketotic hyperglycinemia. Biochem Biophys Res Commun 1991;174:1176-1182.
25. Kure S, Tada K, Narisawa K: Nonketotic hyperglycinemia: Biochemical, molecular, and neurological aspects. Jpn J Hum Genet 1997;42:13-22.
26. Kure S, Takayanagi M, Narisawa K, et al: Identification of a common mutation in Finnish patients with nonketotic hyperglycinemia. J Clin Invest 1992;90:160-164.
27. Kure S, Shinka T, Sakata Y, et al: One-base deletion (183delC) and a missense mutation (D276H) in the AMT gene from a Japanese family with nonketotic hyperglycinemia. J Hum Genet 1998;43:135-137.
28. De Groot CJ, Troelstra JA, Hommes FA: Nonketotic hyperglycinemia: An in vitro study of the glycine-serine conversion in liver of three patients and the effect of dietary methionine. Pediatr Res 1970; 4:238-243.
29. Johnson JW, Ascher P: Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 1987;325:529-531.
30. Holmgren G, Blomquist HK: Nonketotic hyperglycinemia in two sibs with mild psycho-neurological symptoms. Neuropädiatrie 1977;8:67-72.
31. Hamosh A, McDonald JW, Valle D, et al: Dextromethorphan and high-dose benzoate therapy for nonketotic hyperglycinemia in an infant. J Pediatr 1992;121:131-135.